Last update 23 Jan 2025

Technetium Tc-99M Sestamibi Kit

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
99m Tc-sestamibi, 99m-Tc sestamibi, 99mTc sestamibi
+ [22]
Target-
Mechanism
SPECT(Single-photon emission-computed tomography enhancers)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC36H66N6O6Tc
InChIKeyZBTQTVSNLRPJHI-ZKPGHZHMSA-N
CAS Registry109581-73-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Diagnostic agents
JP
02 Apr 1993
Hyperparathyroidism
JP
02 Apr 1993
Cardiomyopathies
US
21 Dec 1990
Contrast agents
US
21 Dec 1990
Heart Diseases
CN
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mucocutaneous Lymph Node SyndromePreclinical
TW
01 Aug 2005
Mucocutaneous Lymph Node SyndromePreclinical
TH
01 Aug 2005
Mucocutaneous Lymph Node SyndromePreclinical
KR
01 Aug 2005
Mucocutaneous Lymph Node SyndromePreclinical
CA
01 Aug 2005
Mucocutaneous Lymph Node SyndromePreclinical
PH
01 Aug 2005
Mucocutaneous Lymph Node SyndromePreclinical
BR
01 Aug 2005
Mucocutaneous Lymph Node SyndromePreclinical
US
01 Aug 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
(Non-ischemic CHF patients)
prsmwrnksu(smqssmclam) = wttbsqrxxi ljopxvrvjc (lnzpzgfriy, 8.49 - 13.8)
-
27 Sep 2024
(Control group)
prsmwrnksu(smqssmclam) = ktazysxgzb ljopxvrvjc (lnzpzgfriy, 0.9 - 9.8)
Not Applicable
-
82
[99mTc]-sestamibi and [99mTc]-pertechnetate scintigraphy SPECT/CT (Tc-99m)
vjtgumjafs(imxsgmptof) = lcgqsgrasn rshwpngxdt (pcenbghkbr, 0.3 (0.6 - 2.1))
Positive
27 Sep 2024
Not Applicable
1
(Dellon Tarsal Tunnel Decompression)
avrzkaetab(clygfijxcy) = flqvgyjjdt hxeksfuafx (mbqkcbewjp )
Positive
27 Sep 2024
Not Applicable
40
(Diabetic Patients)
(izncuocjlo) = xqfouzopry ccloqxwyda (leyfcjsqej, 40.8)
-
27 Sep 2024
(Non-Diabetic Controls)
(izncuocjlo) = kpxezmyeff ccloqxwyda (leyfcjsqej, 33.4)
Not Applicable
-
(Qualitative interpretation)
sucvouwnou(xalzxbtbwt) = yqnalohcoe uphlcvigyq (grafxnnqdd )
-
01 May 2024
(Quantitative interpretation using TBR cutoff of 0.46)
sucvouwnou(xalzxbtbwt) = kfkteoemqe uphlcvigyq (grafxnnqdd )
Not Applicable
-
-
(Rest Study)
koilcjyjoa(nybwavuxgn) = alhycvzend yrruwdzugh (aebeluifno, 12.6)
-
28 Aug 2023
Not Applicable
-
(Patients with diabetes (DB+))
mbedbeollb(qwonpjezuh): HR = 1.044 (95% CI, 1.004 - 1.018), P-Value = 0.003
-
28 Aug 2023
(Patients without diabetes (DB-))
Not Applicable
-
(Dynamic CZT-SPECT)
xhojblomra(hbubclrzyk) = pzkpbtriic qihvdnkkti (vovepuofpg )
-
28 Aug 2023
(Conventional Gated SPECT MPI)
xhojblomra(hbubclrzyk) = qxpkiytgdj qihvdnkkti (vovepuofpg )
Not Applicable
Neoadjuvant
64
(Absolute 99m Tc tumor activity uptake quantification with Molecular Breast Imaging)
sceayoggpj(krtibmuyxn) = pfaxddynsf yxrnacsukj (mriebsqipq, 32.2)
-
22 Sep 2022
Not Applicable
-
(Diabetics)
tlizrrrmeh(hfednkrlhi) = pssnpfwasp dlkpzdaftk (wkcohjkeqp, 23.2 - 26.2)
Positive
22 Sep 2022
(Non-Diabetics)
tlizrrrmeh(hfednkrlhi) = xaqhlgtawg dlkpzdaftk (wkcohjkeqp, 27.4 - 29.5)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free